Apyx Medical Corporation (APYX) is a Healthcare stock trading at $4.10 (as of 2026-06-18), with a market capitalization of $158.70M and a trailing P/E of -18.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Apyx Medical Corporation develops, manufactures, and sells medical devices for cosmetic and surgical uses worldwide. Its products include helium plasma generator systems delivering radiofrequency energy and helium for soft-tissue surgical procedures, as well as Renuvion and J-Plasma device lines, alongside disposable handpieces and OEM generators and accessories.